News
Abbott (NYSE:ABT) today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM ...
Medical Device Network on MSN23h
Glucotrack gains HREC approval for clinical study of CBGM deviceGlucotrack has announced the receipt of St Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback